8-K Announcements
6Material company update
Mar 3, 2026·SEC
Material company update
Feb 26, 2026·SEC
Material company update
Jan 12, 2026·SEC
Delcath Systems, Inc.(DCTH)Earnings, Financials & Key Ratios
DCTH•NASDAQ
$11.26
$391M mkt cap·166.6× P/E·Price updated May 6, 2026
AboutDelcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.Show more
- Revenue$85M+129.1%
- EBITDA$1M+108.3%
- Net Income$3M+110.2%
- EPS (Diluted)0.07+107.3%
- Gross Margin86.16%+3.3%
- EBITDA Margin1.18%+103.6%
- Operating Margin0.77%+102.3%
- Net Margin3.17%+104.5%
- ROE3%+104.8%
- ROIC0.93%+102.5%
- Debt/Equity0.01-44.3%
DCTH Key Insights
Delcath Systems, Inc. (DCTH) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong Piotroski F-Score: 7/9
- ✓FCF machine: 24.6% free cash flow margin
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 120.2%
✗Weaknesses
- ✗Shares diluted 40.0% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
DCTH Price & Volume
Delcath Systems, Inc. (DCTH) stock price & volume — 10-year historical chart
Loading chart...
DCTH Growth Metrics
Delcath Systems, Inc. (DCTH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years47.51%
5 Years120.21%
3 Years215.3%
TTM129.08%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM110.23%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM106.41%
Return on Capital
10 Years-2244.85%
5 Years-129.25%
3 Years-109.34%
Last Year0.72%
DCTH Peer Comparison
Delcath Systems, Inc. (DCTH) competitors in Imaging, radiation, and oncology devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 NVCR | 1.88B | 16.50 | -13.52 | 8.28% | -25.66% | -50.82% | 0.85 | |
 AGEN | 137.4M | 3.89 | -1144.12 | 10.37% | 0.1% | |||
 CLDX | 2.29B | 34.39 | -8.82 | -78.63% | -172.53% | -49.09% | 0.00 | |
 IMVT | 5.83B | 28.67 | -10.50 | -47.07% | 0.00 | |||
 HALO | 7.81B | 66.35 | 25.92 | 37.55% | 22.69% | 6.49% | ||
 INVA | 1.91B | 22.52 | 6.82 | 18.52% | 118.91% | 46.47% | 0.23 | |
 TGTX | 6.7B | 41.97 | 15.15 | 87.32% | 65.95% | 87.36% | 0.40 | |
 RCUS | 2.62B | 26.00 | -7.90 | -4.26% | -156.36% | -68.97% | 0.16 |
Compare DCTH vs Peers
Delcath Systems, Inc. (DCTH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
DCTH Income Statement
Delcath Systems, Inc. (DCTH) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 2.71M | 3.41M | 1.58M | 1.65M | 3.56M | 2.72M | 2.06M | 37.2M | 85.23M |
| Revenue Growth % | 36.3% | 25.49% | -53.62% | 4.18% | 115.98% | -23.52% | -24.05% | 1701.69% | 129.08% |
| Cost of Goods Sold | 701K | 1.01M | 719K | 640K | 671K | 686K | 635K | 6.19M | 11.8M |
| COGS % of Revenue | 25.82% | 29.62% | 45.51% | 38.88% | 18.87% | 25.23% | 30.75% | 16.63% | 13.84% |
| Gross Profit | 2.01M▲ 0% | 2.4M▲ 19.1% | 861K▼ 64.1% | 1.01M▲ 16.8% | 2.88M▲ 186.7% | 2.03M▼ 29.5% | 1.43M▼ 29.7% | 31.02M▲ 2069.0% | 73.43M▲ 136.8% |
| Gross Margin % | 74.18% | 70.38% | 54.49% | 61.12% | 81.13% | 74.77% | 69.25% | 83.37% | 86.16% |
| Gross Profit Growth % | 39.67% | 19.07% | -64.1% | 16.84% | 186.68% | -29.51% | -29.66% | 2069.02% | 136.75% |
| Operating Expenses | 20.18M | 29.47M | 20.77M | 22.31M | 27.41M | 35.89M | 39.61M | 43.43M | 72.77M |
| OpEx % of Revenue | 743.24% | 864.95% | 1314.49% | 1355.35% | 771.17% | 1319.82% | 1918.26% | 116.72% | 85.38% |
| Selling, General & Admin | 9.68M | 9.82M | 11.28M | 11.11M | 13.64M | 17.3M | 22.11M | 29.55M | 43.53M |
| SG&A % of Revenue | 356.69% | 288.2% | 713.86% | 674.85% | 383.6% | 636.37% | 1070.7% | 79.43% | 51.07% |
| Research & Development | 10.49M | 19.65M | 9.49M | 11.2M | 13.78M | 18.58M | 17.5M | 13.87M | 29.25M |
| R&D % of Revenue | 386.56% | 576.75% | 600.63% | 680.5% | 387.57% | 683.45% | 847.55% | 37.29% | 34.31% |
| Other Operating Expenses | -41K | 51K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.16M▲ 0% | -27.07M▼ 49.0% | -19.91M▲ 26.5% | -21.3M▼ 7.0% | -24.53M▼ 15.2% | -33.85M▼ 38.0% | -38.18M▼ 12.8% | -12.41M▲ 67.5% | 660K▲ 105.3% |
| Operating Margin % | -669.06% | -794.57% | -1260% | -1294.23% | -690.04% | -1245.05% | -1849.01% | -33.36% | 0.77% |
| Operating Income Growth % | -10.49% | -49.03% | 26.46% | -7.01% | -15.15% | -38% | -12.79% | 67.5% | 105.32% |
| EBITDA | -17.86M | -26.63M | -19.66M | -21.14M | -24.39M | -33.72M | -37.78M | -12.18M | 1.01M |
| EBITDA Margin % | -657.64% | -781.54% | -1244.24% | -1284.08% | -685.94% | -1240.2% | -1829.69% | -32.74% | 1.18% |
| EBITDA Growth % | -10.66% | -49.13% | 26.17% | -7.51% | -15.37% | -38.29% | -12.05% | 67.76% | 108.28% |
| D&A (Non-Cash Add-back) | 310K | 444K | 249K | 167K | 146K | 132K | 399K | 229K | 349K |
| EBIT | -23.41M | -11.26M | -4.13M | -23.98M | -24.46M | -33.82M | -38.18M | -12.41M | 3.51M |
| Net Interest Income | -21.7M | -7.96M | -4.75M | -175K | -1.19M | -2.69M | -1.44M | 0 | 2.92M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.92M |
| Interest Expense | 21.7M | 7.96M | 4.75M | 175K | 1.19M | 2.69M | 1.44M | 0 | 0 |
| Other Income/Expense | -26.95M | 7.85M | 11.03M | -2.85M | -1.12M | -2.65M | -9.5M | -13.98M | 2.85M |
| Pretax Income | -45.12M▲ 0% | -19.22M▲ 57.4% | -8.88M▲ 53.8% | -24.16M▼ 172.1% | -25.65M▼ 6.2% | -36.51M▼ 42.3% | -47.68M▼ 30.6% | -26.39M▲ 44.7% | 3.51M▲ 113.3% |
| Pretax Margin % | -1661.77% | -564.19% | -561.96% | -1467.56% | -721.49% | -1342.7% | -2308.86% | -70.92% | 4.12% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 810K |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 23.08% |
| Net Income | -45.12M▲ 0% | -19.22M▲ 57.4% | -8.88M▲ 53.8% | -24.16M▼ 172.1% | -25.65M▼ 6.2% | -36.51M▼ 42.3% | -47.68M▼ 30.6% | -26.39M▲ 44.7% | 2.7M▲ 110.2% |
| Net Margin % | -1661.77% | -564.19% | -561.96% | -1467.56% | -721.49% | -1342.7% | -2308.86% | -70.92% | 3.17% |
| Net Income Growth % | -151.05% | 57.4% | 53.81% | -172.06% | -6.18% | -42.34% | -30.6% | 44.66% | 110.23% |
| Net Income (Continuing) | -45.12M | -19.22M | -8.88M | -24.16M | -25.65M | -36.51M | -47.68M | -26.39M | 2.7M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -999999.00▲ 0% | -503.85▲ 99.9% | -342.82▲ 32.0% | -8.35▲ 97.6% | -3.59▲ 57.0% | -4.12▼ 14.7% | -2.94▲ 28.7% | -0.93▲ 68.5% | 0.07▲ 107.3% |
| EPS Growth % | 99.83% | 99.98% | 31.96% | 97.56% | 57.04% | -14.74% | 28.67% | 68.5% | 107.3% |
| EPS (Basic) | -999999.00 | -503.85 | -342.82 | -8.35 | -3.59 | -4.12 | -2.94 | -0.93 | 0.08 |
| Diluted Shares Outstanding | 20 | 38.15K | 25.9K | 2.9M | 7.15M | 8.86M | 16.23M | 28.51M | 39.92M |
| Basic Shares Outstanding | 20 | 38.15K | 25.9K | 2.9M | 7.15M | 8.86M | 16.23M | 28.51M | 35.82M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
DCTH Balance Sheet
Delcath Systems, Inc. (DCTH) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 7.59M | 5.92M | 12.62M | 32.34M | 31.15M | 16.16M | 37.16M | 73.76M | 119.53M |
| Cash & Short-Term Investments | 4M | 2.52M | 10M | 28.57M | 22.8M | 7.67M | 32.45M | 53.23M | 91.04M |
| Cash Only | 4M | 2.52M | 10M | 28.57M | 22.8M | 7.67M | 12.65M | 32.41M | 43.45M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 19.81M | 20.82M | 47.58M |
| Accounts Receivable | 317K | 1.16M | 21K | 57K | 44K | 366K | 483K | 11.06M | 11.74M |
| Days Sales Outstanding | 42.62 | 124.7 | 4.85 | 12.64 | 4.52 | 49.13 | 85.37 | 108.5 | 50.29 |
| Inventory | 1.25M | 858K | 654K | 855K | 1.41M | 2M | 3.32M | 6.93M | 10.25M |
| Days Inventory Outstanding | 649.81 | 310.38 | 332 | 487.62 | 768.08 | 1.06K | 1.91K | 408.94 | 317.2 |
| Other Current Assets | 1.47M | 1.19M | 626K | 509K | 4.36M | 4.25M | 387K | 1.39M | 6.5M |
| Total Non-Current Assets | 1.3M | 925K | 1.59M | 2.3M | 1.97M | 1.71M | 1.46M | 2.83M | 4.1M |
| Property, Plant & Equipment | 1.3M | 925K | 1.59M | 2.3M | 1.97M | 1.71M | 1.46M | 2.83M | 4.1M |
| Fixed Asset Turnover | 2.09x | 3.68x | 0.99x | 0.72x | 1.80x | 1.59x | 1.42x | 13.15x | 20.78x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 8.89M▲ 0% | 6.84M▼ 23.0% | 14.21M▲ 107.7% | 34.63M▲ 143.7% | 33.12M▼ 4.4% | 17.86M▼ 46.1% | 38.61M▲ 116.2% | 76.59M▲ 98.4% | 123.63M▲ 61.4% |
| Asset Turnover | 0.31x | 0.50x | 0.11x | 0.05x | 0.11x | 0.15x | 0.05x | 0.49x | 0.69x |
| Asset Growth % | -74.78% | -22.99% | 107.66% | 143.7% | -4.36% | -46.08% | 116.17% | 98.35% | 61.42% |
| Total Current Liabilities | 7.81M | 17.75M | 15.99M | 10.04M | 5.95M | 14.73M | 16.45M | 6.14M | 10.95M |
| Accounts Payable | 3.85M | 7.71M | 4.53M | 1.77M | 638K | 2.02M | 1.01M | 961K | 2.66M |
| Days Payables Outstanding | 2K | 2.79K | 2.3K | 1.01K | 347.05 | 1.07K | 581.7 | 56.68 | 82.24 |
| Short-Term Debt | 0 | 2.04M | 0 | 2M | 621K | 7.85M | 10.15M | 0 | 0 |
| Deferred Revenue (Current) | 0 | 3.4M | 482K | 525K | 170K | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.84M | 6.21M | 9.39M | 4.3M | 2.41M | 1.04M | 1.93M | 3.71M | 8.19M |
| Current Ratio | 0.97x | 0.33x | 0.79x | 3.22x | 5.23x | 1.10x | 2.26x | 12.01x | 10.92x |
| Quick Ratio | 0.81x | 0.29x | 0.75x | 3.14x | 4.99x | 0.96x | 2.06x | 10.88x | 9.98x |
| Cash Conversion Cycle | -1.31K | -2.36K | -1.96K | -511.48 | 425.55 | 38.49 | 1.41K | 460.76 | 285.25 |
| Total Non-Current Liabilities | 395K | 4.03M | 4.58M | 2.52M | 15.22M | 8.99M | 6.39M | 1.7M | 1.46M |
| Long-Term Debt | 0 | 0 | 2M | 0 | 15.01M | 7.84M | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 197K | 450K | 207K | 0 | 0 | 933K | 835K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 395K | 628K | 0 | 0 | 0 | 1.14M | 6.39M | 766K | 628K |
| Total Liabilities | 8.21M | 21.78M | 20.57M | 12.56M | 21.17M | 23.72M | 22.84M | 7.84M | 12.41M |
| Total Debt | 0 | 2.04M | 2.86M | 2.94M | 16.25M | 15.87M | 10.19M | 1.04M | 936K |
| Net Debt | -4M | -478K | -7.14M | -25.63M | -6.55M | 8.2M | -2.46M | -31.37M | -42.52M |
| Debt / Equity | - | - | - | 0.13x | 1.36x | - | 0.65x | 0.02x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | 0.93x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | -42.14x |
| Interest Coverage | -1.08x | -1.42x | -0.87x | -137.03x | -20.63x | -12.60x | -26.53x | - | - |
| Total Equity | 678K▲ 0% | -14.94M▼ 2303.4% | -6.36M▲ 57.4% | 22.08M▲ 447.3% | 11.95M▼ 45.9% | -5.86M▼ 149.0% | 15.78M▲ 369.3% | 68.75M▲ 335.7% | 111.22M▲ 61.8% |
| Equity Growth % | 145.5% | -2303.39% | 57.45% | 447.3% | -45.86% | -149.02% | 369.28% | 335.74% | 61.78% |
| Book Value per Share | 33772.94 | -391.59 | -245.44 | 7.62 | 1.67 | -0.66 | 0.97 | 2.41 | 2.79 |
| Total Shareholders' Equity | 678K | -14.94M | -6.36M | 22.08M | 11.95M | -5.86M | 15.78M | 68.75M | 111.22M |
| Common Stock | 1.14M | 103K | 1K | 60K | 79K | 100K | 228K | 331K | 347K |
| Retained Earnings | -324.83M | -344.05M | -371.17M | -395.33M | -420.98M | -457.48M | -505.16M | -531.55M | -528.85M |
| Treasury Stock | -51K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 42K | 50K | 28K | -104K | 18K | -83K | 135K | 82K | 575K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DCTH Cash Flow Statement
Delcath Systems, Inc. (DCTH) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -15.4M | -14.73M | -23.69M | -22.87M | -22.6M | -24.95M | -31.25M | -18.68M | 22.52M |
| Operating CF Margin % | -567.15% | -432.4% | -1499.3% | -1389.31% | -635.84% | -917.62% | -1513.37% | -50.21% | 26.42% |
| Operating CF Growth % | -8.34% | 4.33% | -60.8% | 3.47% | 1.15% | -10.38% | -25.25% | 40.22% | 220.53% |
| Net Income | -45.12M | -19.22M | -8.88M | -24.16M | -25.65M | -36.51M | -47.68M | -26.39M | 2.7M |
| Depreciation & Amortization | 310K | 444K | 249K | 192K | 146K | 132K | 128K | 229K | 349K |
| Stock-Based Compensation | 129K | 58K | 277K | 3.91M | 7.83M | 7.94M | 8.15M | 9.77M | 24.23M |
| Deferred Taxes | 5.23M | -15.76M | 0 | 2.83M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 21.54M | 7.97M | -9.77M | 159K | 831K | 1.37M | 9.05M | 13.23M | -1.7M |
| Working Capital Changes | 2.51M | 11.77M | -5.56M | -5.81M | -5.76M | 2.11M | -906K | -15.52M | -3.07M |
| Change in Receivables | 108K | -293K | 497K | -36K | 13K | -322K | 125K | -10.65M | -854K |
| Change in Inventory | -543K | 385K | 204K | -201K | -557K | -587K | -1.32M | -3.61M | -3.32M |
| Change in Payables | 3.18M | 8.18M | -4.79M | -5.31M | -1.14M | 1.8M | -199K | 479K | 4.77M |
| Cash from Investing | -524K | -76K | -24K | -782K | -143K | -209K | -19.71M | -981K | -26.59M |
| Capital Expenditures | -524K | -76K | -24K | -782K | -143K | -209K | -58K | -559K | -1.55M |
| CapEx % of Revenue | 19.3% | 2.23% | 1.52% | 47.51% | 4.02% | 7.69% | 2.81% | 1.5% | 1.82% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 15.45M | 13.24M | 30.3M | 42.35M | 20.82M | 10.14M | 51.78M | 39.41M | 15.05M |
| Debt Issued (Net) | 0 | 794K | 3.68M | -26K | 14.44M | -714K | -6.31M | -10.61M | 0 |
| Equity Issued (Net) | 0 | 0 | 26.63M | 39.76M | 3.92M | 10.86M | 23.08M | 7.02M | 15.05M |
| Dividends Paid | -527K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6M |
| Other Financing | 2.85M | 12.44M | 0 | 2.62M | 2.46M | 0 | 35.01M | 43M | 0 |
| Net Change in Cash | -410K▲ 0% | -1.75M▼ 325.9% | 6.61M▲ 478.4% | 18.57M▲ 181.2% | -1.8M▼ 109.7% | -15.13M▼ 739.2% | 874K▲ 105.8% | 19.72M▲ 2155.8% | 11.04M▼ 44.0% |
| Free Cash Flow | -15.92M▲ 0% | -14.81M▲ 7.0% | -23.71M▼ 60.1% | -23.65M▲ 0.3% | -22.75M▲ 3.8% | -25.16M▼ 10.6% | -31.31M▼ 24.4% | -19.24M▲ 38.5% | 20.97M▲ 209.0% |
| FCF Margin % | -586.45% | -434.63% | -1500.82% | -1436.82% | -639.86% | -925.3% | -1516.17% | -51.71% | 24.6% |
| FCF Growth % | -10.03% | 7% | -60.14% | 0.27% | 3.82% | -10.6% | -24.44% | 38.55% | 208.99% |
| FCF per Share | -793116.15 | -388.15 | -915.56 | -8.16 | -3.18 | -2.84 | -1.93 | -0.67 | 0.53 |
| FCF Conversion (FCF/Net Income) | 0.34x | 0.77x | 2.67x | 0.95x | 0.88x | 0.68x | 0.66x | 0.71x | 8.34x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DCTH Key Ratios
Delcath Systems, Inc. (DCTH) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -505.44% | -6654.42% | - | - | -307.31% | -150.74% | -1198.36% | -961.44% | -62.44% | 3% |
| Return on Invested Capital (ROIC) | -717.28% | -660.87% | - | - | - | -1985.78% | -655.3% | -365.68% | -36.72% | 0.93% |
| Gross Margin | 72.39% | 74.18% | 70.38% | 54.49% | 61.12% | 81.13% | 74.77% | 69.25% | 83.37% | 86.16% |
| Net Margin | -902.16% | -1661.77% | -564.19% | -561.96% | -1467.56% | -721.49% | -1342.7% | -2308.86% | -70.92% | 3.17% |
| Debt / Equity | - | - | - | - | 0.13x | 1.36x | - | 0.65x | 0.02x | 0.01x |
| Interest Coverage | -0.25x | -1.08x | -1.42x | -0.87x | -137.03x | -20.63x | -12.60x | -26.53x | - | - |
| FCF Conversion | 0.79x | 0.34x | 0.77x | 2.67x | 0.95x | 0.88x | 0.68x | 0.66x | 0.71x | 8.34x |
| Revenue Growth | 14.02% | 36.3% | 25.49% | -53.62% | 4.18% | 115.98% | -23.52% | -24.05% | 1701.69% | 129.08% |
DCTH SEC Filings & Documents
Delcath Systems, Inc. (DCTH) SEC filings — annual & quarterly reports (10-K, 10-Q)
DCTH Frequently Asked Questions
Delcath Systems, Inc. (DCTH) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Delcath Systems, Inc. (DCTH) reported $85.2M in revenue for fiscal year 2025.
Delcath Systems, Inc. (DCTH) grew revenue by 129.1% over the past year. This is strong growth.
Yes, Delcath Systems, Inc. (DCTH) is profitable, generating $2.7M in net income for fiscal year 2025 (3.2% net margin).
Dividend & Returns
Delcath Systems, Inc. (DCTH) has a return on equity (ROE) of 3.0%. This is below average, suggesting room for improvement.
Delcath Systems, Inc. (DCTH) generated $21.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More DCTH
Delcath Systems, Inc. (DCTH) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates